SIMILAR PATTERNS OF AMINO ACIDS FOR 1XOM_B_CIOB601_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1cx1 | ENDOGLUCANASE C (Cellulomonasfimi) |
PF02018(CBM_4_9) | 5 | LEU A 68ILE A 143MET A 37PHE A 15PHE A 131 | None | 1.33A | 1xomB-1cx1A:undetectable | 1xomB-1cx1A:18.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dct | PROTEIN(MODIFICATIONMETHYLASE HAEIII) (Haemophilusinfluenzae) |
PF00145(DNA_methylase) | 5 | LEU A 90ILE A 97PHE A 59SER A 5PHE A 7 | None | 1.17A | 1xomB-1dctA:undetectable | 1xomB-1dctA:19.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gtu | GLUTATHIONES-TRANSFERASE (Homo sapiens) |
PF02798(GST_N)PF14497(GST_C_3) | 5 | TYR A 126LEU A 165ILE A 113PHE A 119PHE A 208 | None | 1.14A | 1xomB-1gtuA:undetectable | 1xomB-1gtuA:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1js8 | HEMOCYANIN (Enteroctopusdofleini) |
PF00264(Tyrosinase)PF14830(Haemocyan_bet_s) | 5 | HIS A2671LEU A2574THR A2566MET A2564GLN A2561 | CUO A 888 (-3.4A)NoneNoneNoneNone | 1.30A | 1xomB-1js8A:undetectable | 1xomB-1js8A:23.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1m2p | CASEIN KINASE II,ALPHA CHAIN (Zea mays) |
PF00069(Pkinase) | 5 | HIS A 154LEU A 85ILE A 174MET A 163PHE A 113 | NoneNoneHNA A 351 (-3.8A)HNA A 351 ( 3.8A)HNA A 351 (-3.6A) | 1.43A | 1xomB-1m2pA:undetectable | 1xomB-1m2pA:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mio | NITROGENASEMOLYBDENUM IRONPROTEIN (BETA CHAIN) (Clostridiumpasteurianum) |
PF00148(Oxidored_nitro) | 5 | TYR B 118LEU B 111ILE B 84SER B 70PHE B 71 | None | 1.46A | 1xomB-1mioB:undetectable | 1xomB-1mioB:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qbg | NAD(P)HDEHYDROGENASE[QUINONE] 1 (Homo sapiens) |
PF02525(Flavodoxin_2) | 5 | THR A 148ILE A 192PHE A 17MET A 21SER A 145 | FAD A 501 (-3.9A)FAD A 501 (-4.5A)FAD A 501 (-4.9A)NoneNone | 1.10A | 1xomB-1qbgA:undetectable | 1xomB-1qbgA:20.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1r55 | ADAM 33 (Homo sapiens) |
PF01421(Reprolysin) | 5 | MET A 319LEU A 405THR A 250MET A 373SER A 389 | None | 1.45A | 1xomB-1r55A:undetectable | 1xomB-1r55A:17.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rep | PROTEIN (REPLICATIONINITIATION PROTEIN) (Escherichiacoli) |
PF01051(Rep_3) | 5 | TYR C 192LEU C 169ILE C 188PHE C 204PHE C 240 | None | 1.43A | 1xomB-1repC:undetectable | 1xomB-1repC:20.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 736HIS A 737THR A 952ILE A 955PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)IBM A2111 ( 4.8A)IBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.54A | 1xomB-1sojA:42.3 | 1xomB-1sojA:31.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1u2v | ACTIN-RELATEDPROTEIN 3ARP2/3 COMPLEX 34KDASUBUNIT (Bos taurus) |
PF00022(Actin)PF04045(P34-Arc) | 5 | HIS D 263THR A 126ILE A 129MET A 130PHE A 134 | None | 1.27A | 1xomB-1u2vD:undetectable | 1xomB-1u2vD:21.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uf2 | CORE PROTEIN P3 (Rice dwarfvirus) |
PF09231(RDV-p3) | 5 | LEU A 642THR A 559ILE A 562SER A 589PHE A 591 | None | 1.38A | 1xomB-1uf2A:undetectable | 1xomB-1uf2A:16.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wu2 | MOLYBDOPTERINBIOSYNTHESIS MOEAPROTEIN (Pyrococcushorikoshii) |
PF00994(MoCF_biosynth)PF03453(MoeA_N)PF03454(MoeA_C) | 5 | TYR A 10LEU A 17ILE A 281SER A 297PHE A 287 | None | 1.41A | 1xomB-1wu2A:undetectable | 1xomB-1wu2A:22.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zkl | HIGH-AFFINITYCAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 7A (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 211HIS A 212PHE A 384GLN A 413PHE A 416 | IBM A 503 (-4.6A)NoneIBM A 503 (-4.5A)IBM A 503 (-3.0A)IBM A 503 (-3.4A) | 0.61A | 1xomB-1zklA:45.4 | 1xomB-1zklA:33.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1znp | HYPOTHETICAL PROTEINATU3615 (Agrobacteriumfabrum) |
PF06172(Cupin_5) | 5 | TYR A 25HIS A 19THR A 28ILE A 43SER A 40 | None | 1.35A | 1xomB-1znpA:undetectable | 1xomB-1znpA:16.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a3v | SITE-SPECIFICRECOMBINASE INTI4 (Vibrio cholerae) |
PF00589(Phage_integrase)PF13495(Phage_int_SAM_4) | 5 | LEU A 83THR A 31ILE A 34SER A 3PHE A 5 | None | 1.21A | 1xomB-2a3vA:undetectable | 1xomB-2a3vA:22.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2avt | DNA POLYMERASE IIIBETA SUBUNIT (Streptococcuspyogenes) |
PF00712(DNA_pol3_beta)PF02767(DNA_pol3_beta_2)PF02768(DNA_pol3_beta_3) | 5 | LEU A 325ILE A 299PHE A 266SER A 319GLN A 320 | None | 1.37A | 1xomB-2avtA:undetectable | 1xomB-2avtA:23.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eyu | TWITCHING MOTILITYPROTEIN PILT (Aquifexaeolicus) |
PF00437(T2SSE) | 5 | MET A 218LEU A 140THR A 152ILE A 153SER A 147 | None | 1.46A | 1xomB-2eyuA:undetectable | 1xomB-2eyuA:20.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eyu | TWITCHING MOTILITYPROTEIN PILT (Aquifexaeolicus) |
PF00437(T2SSE) | 5 | MET A 218THR A 152ILE A 153SER A 147GLN A 279 | None | 1.47A | 1xomB-2eyuA:undetectable | 1xomB-2eyuA:20.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h18 | ADP-RIBOSYLATIONFACTOR-LIKE PROTEIN8A (Homo sapiens) |
PF00025(Arf) | 5 | LEU A 128THR A 24ILE A 67MET A 21SER A 90 | None | 1.20A | 1xomB-2h18A:undetectable | 1xomB-2h18A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h2q | BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE (Trypanosomacruzi) |
PF00186(DHFR_1)PF00303(Thymidylat_synt) | 5 | LEU A 496THR A 375ILE A 372MET A 385PHE A 409 | None | 1.50A | 1xomB-2h2qA:undetectable | 1xomB-2h2qA:19.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 371HIS A 372MET A 485LEU A 531THR A 545ILE A 548MET A 549PHE A 552MET A 569SER A 580GLN A 581PHE A 584 | NPV A 3 (-4.4A)NPV A 3 (-4.6A)NoneNoneNPV A 3 ( 4.7A)NPV A 3 (-3.8A)NPV A 3 ( 4.7A)NPV A 3 (-4.8A)NPV A 3 (-3.1A)NPV A 3 (-4.5A)NPV A 3 (-3.1A)NPV A 3 (-3.3A) | 0.43A | 1xomB-2qykA:52.0 | 1xomB-2qykA:82.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qyk | CYCLIC AMP-SPECIFICPHOSPHODIESTERASEHSPDE4A10 (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 371HIS A 376MET A 485THR A 545SER A 580GLN A 581PHE A 584 | NPV A 3 (-4.4A) ZN A 1 (-3.3A)NoneNPV A 3 ( 4.7A)NPV A 3 (-4.5A)NPV A 3 (-3.1A)NPV A 3 (-3.3A) | 1.48A | 1xomB-2qykA:52.0 | 1xomB-2qykA:82.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qym | PHOSPHODIESTERASE 4C (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 281HIS A 282MET A 395LEU A 441THR A 455ILE A 458PHE A 494 | None | 0.46A | 1xomB-2qymA:43.6 | 1xomB-2qymA:82.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r8q | CLASS IPHOSPHODIESTERASEPDEB1 (Leishmaniamajor) |
PF00233(PDEase_I) | 7 | TYR A 680HIS A 681MET A 797PHE A 857MET A 874GLN A 887PHE A 890 | IBM A 3 ( 4.7A)IBM A 3 ( 4.8A)NoneIBM A 3 (-4.9A)IBM A 3 ( 3.8A)IBM A 3 (-3.3A)IBM A 3 (-3.6A) | 0.83A | 1xomB-2r8qA:39.4 | 1xomB-2r8qA:30.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x1m | METHIONYL-TRNASYNTHETASE (Mycolicibacteriumsmegmatis) |
PF09334(tRNA-synt_1g) | 5 | TYR A 45MET A 409THR A 8ILE A 7PHE A 5 | None | 1.15A | 1xomB-2x1mA:undetectable | 1xomB-2x1mA:22.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xgt | ASPARAGINYL-TRNASYNTHETASE,CYTOPLASMIC (Brugia malayi) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 5 | THR A 174ILE A 133MET A 136PHE A 146MET A 144 | None | 1.42A | 1xomB-2xgtA:undetectable | 1xomB-2xgtA:21.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3b2r | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 612HIS A 613LEU A 765PHE A 786GLN A 817PHE A 820 | VDN A 1 (-4.8A)VDN A 1 (-4.3A)VDN A 1 ( 4.7A)NoneVDN A 1 (-3.0A)VDN A 1 (-3.6A) | 0.68A | 1xomB-3b2rA:31.6 | 1xomB-3b2rA:31.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bjc | CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 612HIS A 613LEU A 765PHE A 786GLN A 817PHE A 820 | None MG A 877 (-4.4A)WAN A 901 ( 4.7A)WAN A 901 (-4.8A)WAN A 901 (-3.1A)WAN A 901 (-3.7A) | 0.71A | 1xomB-3bjcA:34.3 | 1xomB-3bjcA:17.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ecn | HIGH AFFINITYCAMP-SPECIFIC ANDIBMX-INSENSITIVE3',5'-CYCLICPHOSPHODIESTERASE 8A (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 555HIS A 556MET A 670ILE A 744SER A 777GLN A 778PHE A 781 | NoneNoneIBM A 3 (-4.5A)IBM A 3 (-4.3A)NoneIBM A 3 (-3.4A)IBM A 3 (-3.5A) | 0.41A | 1xomB-3ecnA:45.0 | 1xomB-3ecnA:33.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 325HIS A 326MET A 439LEU A 485ILE A 502MET A 503PHE A 506SER A 534PHE A 538 | NoneD71 A 901 (-4.5A)D71 A 901 ( 4.0A)NoneD71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 (-4.8A)D71 A 901 (-3.4A)D71 A 901 (-3.9A) | 0.88A | 1xomB-3g4gA:52.8 | 1xomB-3g4gA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 10 | TYR A 325HIS A 326MET A 439LEU A 485THR A 499ILE A 502MET A 503PHE A 506GLN A 535PHE A 538 | NoneD71 A 901 (-4.5A)D71 A 901 ( 4.0A)NoneD71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 (-4.8A)D71 A 901 (-3.1A)D71 A 901 (-3.9A) | 0.66A | 1xomB-3g4gA:52.8 | 1xomB-3g4gA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 325ILE A 502MET A 503MET A 523SER A 534PHE A 538 | NoneD71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 ( 4.0A)D71 A 901 (-3.4A)D71 A 901 (-3.9A) | 1.02A | 1xomB-3g4gA:52.8 | 1xomB-3g4gA:81.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g4g | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 325THR A 499ILE A 502MET A 503MET A 523GLN A 535PHE A 538 | NoneD71 A 901 (-3.6A)D71 A 901 (-4.1A)D71 A 901 (-3.6A)D71 A 901 ( 4.0A)D71 A 901 (-3.1A)D71 A 901 (-3.9A) | 0.70A | 1xomB-3g4gA:52.8 | 1xomB-3g4gA:81.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gwj | ARYLPHORIN (Antheraeapernyi) |
PF00372(Hemocyanin_M)PF03722(Hemocyanin_N)PF03723(Hemocyanin_C) | 5 | LEU A 154THR A 295PHE A 395SER A 298PHE A 297 | None | 1.39A | 1xomB-3gwjA:undetectable | 1xomB-3gwjA:18.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h5c | PROTEIN Z-DEPENDENTPROTEASE INHIBITOR (Homo sapiens) |
PF00079(Serpin) | 5 | LEU A 362ILE A 203PHE A 174MET A 172PHE A 200 | None | 1.44A | 1xomB-3h5cA:undetectable | 1xomB-3h5cA:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hoc | FILAMIN-A (Homo sapiens) |
PF00307(CH) | 5 | LEU A 172THR A 186ILE A 185SER A 189PHE A 188 | None | 1.33A | 1xomB-3hocA:undetectable | 1xomB-3hocA:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hzt | CALCIUM-DEPENDENTPROTEIN KINASE 3 (Toxoplasmagondii) |
PF00069(Pkinase)PF13499(EF-hand_7) | 5 | TYR A 242MET A 180LEU A 268GLN A 360PHE A 162 | None | 1.48A | 1xomB-3hztA:undetectable | 1xomB-3hztA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ibj | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I)PF01590(GAF)PF13185(GAF_2) | 6 | TYR A 655HIS A 656LEU A 809ILE A 826GLN A 859PHE A 862 | None | 1.04A | 1xomB-3ibjA:32.8 | 1xomB-3ibjA:18.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jbl | NLR FAMILY CARDDOMAIN-CONTAININGPROTEIN 4 (Mus musculus) |
no annotation | 5 | TYR K 493THR K 450PHE K 363GLN K 447PHE K 406 | None | 1.31A | 1xomB-3jblK:undetectable | 1xomB-3jblK:18.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ldg | PUTATIVEUNCHARACTERIZEDPROTEIN SMU.472 (Streptococcusmutans) |
PF01170(UPF0020)PF02926(THUMP) | 5 | LEU A 292ILE A 341PHE A 348GLN A 339PHE A 331 | SAH A 385 (-3.8A)NoneNoneNoneNone | 1.17A | 1xomB-3ldgA:undetectable | 1xomB-3ldgA:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 233HIS A 234MET A 347LEU A 393THR A 407ILE A 410MET A 411MET A 431SER A 442GLN A 443PHE A 446 | NoneNoneZG2 A 506 (-3.9A)NoneZG2 A 506 (-4.3A)ZG2 A 506 (-4.4A)NoneZG2 A 506 (-3.4A)NoneZG2 A 506 (-3.3A)ZG2 A 506 (-3.6A) | 0.64A | 1xomB-3o57A:51.9 | 1xomB-3o57A:82.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o57 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 233HIS A 234MET A 347LEU A 393THR A 407ILE A 410MET A 411PHE A 414SER A 442GLN A 443PHE A 446 | NoneNoneZG2 A 506 (-3.9A)NoneZG2 A 506 (-4.3A)ZG2 A 506 (-4.4A)NoneZG2 A 506 (-4.4A)NoneZG2 A 506 (-3.3A)ZG2 A 506 (-3.6A) | 0.59A | 1xomB-3o57A:51.9 | 1xomB-3o57A:82.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
PF00233(PDEase_I) | 12 | TYR A 159HIS A 160MET A 273LEU A 319THR A 333ILE A 336MET A 337PHE A 340MET A 357SER A 368GLN A 369PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)LEU A 319 ( 0.6A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)PHE A 340 (-1.3A)MET A 357 (-0.0A)SER A 368 (-0.0A)GLN A 369 (-0.6A)PHE A 372 (-1.3A) | 0.59A | 1xomB-3sl5A:52.8 | 1xomB-3sl5A:94.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 5 | TYR A 524HIS A 525LEU A 635ILE A 692PHE A 729 | C1L A 1 ( 4.8A)C1L A 1 (-4.1A)NoneC1L A 1 (-4.3A)C1L A 1 (-3.5A) | 1.47A | 1xomB-3ui7A:38.5 | 1xomB-3ui7A:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 524HIS A 525LEU A 675ILE A 692PHE A 696GLN A 726PHE A 729 | C1L A 1 ( 4.8A)C1L A 1 (-4.1A)C1L A 1 (-4.3A)C1L A 1 (-4.3A)C1L A 1 ( 4.7A)C1L A 1 (-2.9A)C1L A 1 (-3.5A) | 0.93A | 1xomB-3ui7A:38.5 | 1xomB-3ui7A:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ui7 | CAMP ANDCAMP-INHIBITED CGMP3',5'-CYCLICPHOSPHODIESTERASE10A (Homo sapiens) |
PF00233(PDEase_I) | 6 | TYR A 524LEU A 675ILE A 692MET A 713GLN A 726PHE A 729 | C1L A 1 ( 4.8A)C1L A 1 (-4.3A)C1L A 1 (-4.3A)C1L A 1 (-3.7A)C1L A 1 (-2.9A)C1L A 1 (-3.5A) | 1.25A | 1xomB-3ui7A:38.5 | 1xomB-3ui7A:28.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3v94 | CYCLIC NUCLEOTIDESPECIFICPHOSPHODIESTERASE (Trypanosomacruzi) |
PF00233(PDEase_I) | 7 | TYR A 367HIS A 368MET A 482ILE A 538PHE A 542GLN A 570PHE A 573 | WYQ A 701 (-4.5A)NoneWYQ A 701 (-4.5A)WYQ A 701 ( 4.1A)WYQ A 701 (-4.7A)WYQ A 701 (-3.3A)WYQ A 701 (-3.4A) | 0.81A | 1xomB-3v94A:40.2 | 1xomB-3v94A:30.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4esa | HEMOGLOBIN BETACHAIN (Eleginopsmaclovinus) |
PF00042(Globin) | 5 | LEU B 71PHE B 122MET B 118SER B 17PHE B 15 | HEM B 202 ( 4.7A)NoneNoneNoneNone | 1.50A | 1xomB-4esaB:undetectable | 1xomB-4esaB:17.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hl6 | UNCHARACTERIZEDPROTEIN YFDE (Escherichiacoli) |
PF02515(CoA_transf_3) | 5 | MET A 106LEU A 97ILE A 119SER A 85PHE A 87 | None | 1.33A | 1xomB-4hl6A:undetectable | 1xomB-4hl6A:25.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 655HIS A 656LEU A 809ILE A 826PHE A 830GLN A 859PHE A 862 | None | 0.67A | 1xomB-4htzA:38.9 | 1xomB-4htzA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4htz | CGMP-DEPENDENT3',5'-CYCLICPHOSPHODIESTERASE (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 655LEU A 809ILE A 826PHE A 830MET A 847GLN A 859PHE A 862 | None | 0.92A | 1xomB-4htzA:38.9 | 1xomB-4htzA:28.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4i15 | CLASS 1PHOSPHODIESTERASEPDEB1 (Trypanosomabrucei) |
PF00233(PDEase_I) | 7 | TYR A 668HIS A 669MET A 785PHE A 844MET A 861GLN A 874PHE A 877 | None | 0.93A | 1xomB-4i15A:38.6 | 1xomB-4i15A:32.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jr7 | CASEIN KINASE IISUBUNIT ALPHA (Saccharomycescerevisiae) |
PF00069(Pkinase) | 5 | HIS A 193LEU A 86ILE A 213MET A 202PHE A 152 | NoneNoneGNP A 401 (-4.6A)GNP A 401 (-3.6A)None | 1.45A | 1xomB-4jr7A:undetectable | 1xomB-4jr7A:23.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4md8 | CASEIN KINASE IISUBUNIT ALPHA (Homo sapiens) |
PF00069(Pkinase) | 5 | HIS E 154LEU E 85ILE E 174MET E 163PHE E 113 | None | 1.33A | 1xomB-4md8E:undetectable | 1xomB-4md8E:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o8m | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Actinobacillussuccinogenes) |
PF03480(DctP) | 5 | THR A 27ILE A 29PHE A 62SER A 56GLN A 253 | None | 1.47A | 1xomB-4o8mA:undetectable | 1xomB-4o8mA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ofz | TREHALOSE-PHOSPHATASE (Brugia malayi) |
no annotation | 5 | MET A 75LEU A 229ILE A 130MET A 119GLN A 224 | None | 1.29A | 1xomB-4ofzA:undetectable | 1xomB-4ofzA:22.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q8g | PAB-DEPENDENTPOLY(A)-SPECIFICRIBONUCLEASE SUBUNITPAN2 (Saccharomycescerevisiae) |
PF13423(UCH_1) | 5 | MET A 703LEU A 735ILE A 695SER A 773PHE A 760 | None | 1.08A | 1xomB-4q8gA:undetectable | 1xomB-4q8gA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q8h | PAB-DEPENDENTPOLY(A)-SPECIFICRIBONUCLEASE SUBUNITPAN2 (Saccharomycescerevisiae) |
PF00929(RNase_T)PF13423(UCH_1) | 5 | MET A 703LEU A 735ILE A 695SER A 773PHE A 760 | None | 1.12A | 1xomB-4q8hA:undetectable | 1xomB-4q8hA:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4v23 | MATRIX PROTEIN (Respiratorysyncytial virus) |
PF03393(Pneumo_matrix) | 5 | MET A 84LEU A 52THR A 33ILE A 34SER A 198 | None | 1.06A | 1xomB-4v23A:undetectable | 1xomB-4v23A:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wmd | ORF1A (Middle Eastrespiratorysyndrome-relatedcoronavirus) |
PF05409(Peptidase_C30) | 5 | TYR A 54MET A 25LEU A 49THR A 88GLN A 167 | NoneNonePGE A 402 ( 4.8A)NoneNone | 1.47A | 1xomB-4wmdA:undetectable | 1xomB-4wmdA:21.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 11 | TYR A 405HIS A 406MET A 519LEU A 565THR A 579ILE A 582MET A 583PHE A 586SER A 614GLN A 615PHE A 618 | None MG A 804 ( 4.9A)NoneNoneNoneNoneNoneNoneNoneNoneNone | 0.62A | 1xomB-4wziA:52.5 | 1xomB-4wziA:48.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 9 | TYR A 405HIS A 406THR A 579ILE A 582MET A 583PHE A 586MET A 603SER A 614GLN A 615 | None MG A 804 ( 4.9A)NoneNoneNoneNoneNoneNoneNone | 0.84A | 1xomB-4wziA:52.5 | 1xomB-4wziA:48.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wzi | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
PF00233(PDEase_I) | 7 | TYR A 405HIS A 410MET A 519LEU A 565THR A 579GLN A 615PHE A 618 | None ZN A 801 (-3.2A)NoneNoneNoneNoneNone | 1.45A | 1xomB-4wziA:52.5 | 1xomB-4wziA:48.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zbl | PHOTOSESITIZERMKILLERORANGE (Hydrozoa) |
PF01353(GFP) | 5 | HIS A 62THR A 162ILE A 163PHE A 165MET A 173 | NoneNone4M9 A 65 ( 4.0A)NoneNone | 1.44A | 1xomB-4zblA:undetectable | 1xomB-4zblA:23.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b25 | CALCIUM/CALMODULIN-DEPENDENT3',5'-CYCLICNUCLEOTIDEPHOSPHODIESTERASE 1B (Homo sapiens) |
PF00233(PDEase_I) | 8 | TYR A 222HIS A 223MET A 336THR A 385PHE A 392SER A 420GLN A 421PHE A 424 | None4QJ A 603 ( 4.9A)4QJ A 603 ( 3.9A)NoneGOL A 607 (-3.9A)4QJ A 603 (-4.7A)4QJ A 603 (-3.0A)4QJ A 603 (-3.5A) | 0.62A | 1xomB-5b25A:44.0 | 1xomB-5b25A:38.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dmh | UNCHARACTERIZEDPROTEIN CONSERVED INBACTERIA (Cupriavidusnecator) |
PF07005(DUF1537)PF17042(DUF1357_C) | 5 | MET A 206LEU A 169ILE A 135SER A 96PHE A 98 | None | 1.47A | 1xomB-5dmhA:undetectable | 1xomB-5dmhA:23.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h2r | PHOSPHODIESTERASE (Trypanosomabrucei) |
no annotation | 7 | TYR A 668HIS A 669MET A 785PHE A 845MET A 862GLN A 875PHE A 878 | LLN A1003 ( 4.8A)NoneLLN A1003 (-4.0A)LLN A1003 (-4.6A)LLN A1003 (-3.5A)LLN A1003 (-3.0A)LLN A1003 (-3.8A) | 0.78A | 1xomB-5h2rA:39.2 | 1xomB-5h2rA:32.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ham | RICKCE (Rickettsiabellii) |
no annotation | 5 | LEU A 580THR A 565ILE A 557MET A 559PHE A 452 | None | 1.11A | 1xomB-5hamA:undetectable | 1xomB-5hamA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ifk | PURINE NUCLEOSIDEPHOSPHORYLASE (Kluyveromyceslactis) |
PF01048(PNP_UDP_1) | 5 | TYR A 19LEU A 24ILE A 65PHE A 68PHE A 82 | None | 1.48A | 1xomB-5ifkA:undetectable | 1xomB-5ifkA:20.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mov | CASEIN KINASE IISUBUNIT ALPHA (Homo sapiens) |
PF00069(Pkinase) | 5 | HIS A 154LEU A 85ILE A 174MET A 163PHE A 113 | NoneNoneHC4 A 401 ( 3.7A)HC4 A 401 ( 4.0A)HC4 A 401 (-3.4A) | 1.43A | 1xomB-5movA:undetectable | 1xomB-5movA:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 11 | TYR A 405HIS A 406MET A 519LEU A 565THR A 579ILE A 582MET A 583PHE A 586MET A 603GLN A 615PHE A 618 | NoneNone9VE A 801 (-3.8A)9VE A 801 (-4.7A)9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 ( 4.0A)9VE A 801 (-3.6A)9VE A 801 (-3.6A)9VE A 801 (-3.2A)9VE A 801 (-3.9A) | 0.58A | 1xomB-5ohjA:52.1 | 1xomB-5ohjA:11.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 11 | TYR A 405HIS A 406MET A 519LEU A 565THR A 579ILE A 582MET A 583PHE A 586SER A 614GLN A 615PHE A 618 | NoneNone9VE A 801 (-3.8A)9VE A 801 (-4.7A)9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 ( 4.0A)9VE A 801 (-3.6A)9VE A 801 (-4.7A)9VE A 801 (-3.2A)9VE A 801 (-3.9A) | 0.29A | 1xomB-5ohjA:52.1 | 1xomB-5ohjA:11.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ohj | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B (Homo sapiens) |
no annotation | 7 | TYR A 405HIS A 410MET A 519LEU A 565THR A 579GLN A 615PHE A 618 | None ZN A 699 (-3.3A)9VE A 801 (-3.8A)9VE A 801 (-4.7A)9VE A 801 (-4.1A)9VE A 801 (-3.2A)9VE A 801 (-3.9A) | 1.47A | 1xomB-5ohjA:52.1 | 1xomB-5ohjA:11.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vyd | PHOSPHODIESTERASE (Salpingoecarosetta) |
no annotation | 5 | HIS A 83MET A 195LEU A 237PHE A 258PHE A 291 | None | 0.64A | 1xomB-5vydA:40.1 | 1xomB-5vydA:32.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 10 | TYR A 159HIS A 160LEU A 319THR A 333ILE A 336MET A 337PHE A 340MET A 357SER A 368GLN A 369 | AKJ A 601 ( 4.7A)NoneAKJ A 601 ( 4.6A)AKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 ( 3.7A)AKJ A 601 (-4.5A)AKJ A 601 (-3.4A)AKJ A 601 (-2.5A)AKJ A 601 (-3.0A) | 0.46A | 1xomB-5wh6A:55.1 | 1xomB-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 11 | TYR A 159HIS A 160MET A 273LEU A 319THR A 333ILE A 336MET A 337PHE A 340MET A 357GLN A 369PHE A 372 | AKJ A 601 ( 4.7A)NoneAKJ A 601 ( 3.9A)AKJ A 601 ( 4.6A)AKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 ( 3.7A)AKJ A 601 (-4.5A)AKJ A 601 (-3.4A)AKJ A 601 (-3.0A)AKJ A 601 (-4.1A) | 0.25A | 1xomB-5wh6A:55.1 | 1xomB-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wh6 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homo sapiens) |
no annotation | 7 | TYR A 159HIS A 164MET A 273LEU A 319THR A 333GLN A 369PHE A 372 | AKJ A 601 ( 4.7A) ZN A 602 (-3.3A)AKJ A 601 ( 3.9A)AKJ A 601 ( 4.6A)AKJ A 601 (-4.1A)AKJ A 601 (-3.0A)AKJ A 601 (-4.1A) | 1.49A | 1xomB-5wh6A:55.1 | 1xomB-5wh6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z9x | SMALL RNA DEGRADINGNUCLEASE 1 (Arabidopsisthaliana) |
no annotation | 5 | HIS A 236LEU A 85THR A 138ILE A 219MET A 140 | None | 1.34A | 1xomB-5z9xA:undetectable | 1xomB-5z9xA:12.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zib | - (-) |
no annotation | 5 | ILE A 317MET A 229PHE A 235MET A 238SER A 302 | None | 1.25A | 1xomB-5zibA:undetectable | 1xomB-5zibA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zic | - (-) |
no annotation | 5 | LEU A 377THR A 306ILE A 305PHE A 235MET A 238 | None | 1.40A | 1xomB-5zicA:undetectable | 1xomB-5zicA:undetectable |